A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Clinical trial NCT03321526 · COMPLETED
Trial details
- NCT number
- NCT03321526
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-12
- Primary completion
- 2019-06-13
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.